We are live on
!
Find out more
ZVSA
ZyVersa Therapeutics
ZVSA
ZVSA
Delisted
ZVSA was delisted on the 16th of July, 2025.
9 hedge funds and large institutions have $73.4K invested in ZyVersa Therapeutics in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
80% more funds holding
Funds holding: 5 → 9 (+4)
0% less ownership
Funds ownership: 0% → 0% (-0%)
73% less capital invested
Capital invested by funds: $273K → $73.4K (-$200K)
Holders
9
Holders Change
+4
Holders Change %
+80%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VF
Virtu Financial
New York
|
+$90.3K |
| 2 |
CAC
Cowen and Company
New York
|
+$37.5K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$29.7K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$27.6K |
| 5 |
SG
StoneX Group
New York
|
+$9.45K |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$200K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$6.33K |